qrxpharma announces strategic partnership with, page-3

I listened to the telephone conference - I must say a very impressive deal with a very impressive strategic partner. This has massive upside growth potential with only US market covered at this stage.

I noted during the conference that in the USA alone there are something in the order of 210+ BILLION pain relief scripts per annum which would fit MoxDuo IR product. They are initially looking at gaining 5% market share as a realistic target. This equates to more than 10 BILLION scripts. This is massive.

As stated, further deals to be done in Europe, Australian and Canada.